Meanwhile, our results from the analyses of publicly available clinical datasets demonstrated that both ILF2 and ILF3 were highly expressed in ESCC tissues compared with the noncancerous tissues and involved in multiple ESCC-related pathways and metabolic pathways. The gene discussed is ILF2; the disease is esophageal squamous cell carcinoma.